Tech Stock News
Tuesday, January 18, 2022
Four publicly traded companies are facing class-action lawsuits. This is the investors’ alert. AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) deadline alert AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is facing a class-action lawsuit. Bronstein, Gewirtz & Grossman, LLC is looking into the investigation part of this lawsuit filed against the publicly traded company. […]
Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) are under investigation for potential federal securities laws violation. AcelRx’s lead candidate DSUVIA AcelRx develops acute pain treatment therapies, and its lead candidate DSUVIA, has FDA approval for acute pain management. On February […]